Current Protein & Peptide Science

Dr. Coskuner-Weber obtained a Ph.D. degree from the Universitaet zu Köln (Germany), then worked at Johns Hopkins University (Maryland, USA). She also worked at the National Institute of Standards and Technology (Maryland, USA) along with an academic appointment at Stanford University (California, USA). Currently, she is an Associate Professor of Molecular Biotechnology at the Turkish-German University (Istanbul, Turkey). She has published more than 40 scientific publications. She has served on the editorial boards of a number of journals and was appointed as Regional Editor of this journal (Protein & Peptide Letters), published by Bentham Science Publishers.

Dr. Predrag Cudic earned his Ph.D. degree in Chemistry from the University of Zagreb, Croatia, in 1996. He then joined group of Nobel Laureate Dr. Jean-Marie Lehn at the Collège de France in Paris as a Postdoctoral Fellow. He had further postdoctoral training at the University of Pennsylvania, Philadelphia. Dr. Cudic began his independent academic career at Florida Atlantic University, Boca Raton, in 2003. In 2010, Dr. Cudic joined Torrey Pines Institute for Molecular Studies and in 2016 he came back to FAU as a tenured Full Professor. His research interests are in the field of peptide drug discovery.

Prof. M. Akhter Hossain completed his Ph.D. in 2001 at Tokyo Institute of Technology (Japan) and undertook postdoctoral studies at Joseph Fourier University (France) and the Howard Florey Institute (Australia). He has been the Head of the Insulin Peptides Laboratory since 2012 at the now- Florey Institute of Neuroscience and Mental Health, University of Melbourne. He has published > 115 papers (from 2000 to mid-2018) in key international journals including the Journal of American Chemical Society, Angewandte Chemie, and Chemical Science. Five of his discoveries have been patented. His research group is interested in designing peptidomimetics and developing novel chemical methods for preparing therapeutic insulin and insulin-like peptides.

Dr. Rizwan Hasan Khan has received his Ph.D in Biotechnology from Aligarh Muslim University, India during the period of 1992-1996. Currently he is working in the area of protein structure, function, protein misfolding / aggregation and amyloid induction and inhibition at Aligarh Muslim University. He has published papers in journals like Scientific reports, Biomacromolecules, Langmuir, PLoS ONE, Biochemistry, BBA, BBRC etc. He has worked with Prof. I.J. Goldstein at University of Michigan USA as BOYSCAST Fellow and with Prof. Steve Perkins at University of London as Commonwealth Fellow. He has guided 16 PhD theses and completed 12 research projects. He had published around 250 papers in the journals of international repute with H index of 35 and total citation around 4650.

Anna Maria Papini is a bioorganic chemist expert in peptide and protein chemistry and biology. She completed an International PhD in bioorganic chemistry in 1990, under the supervision of Prof. Luis Moroder of the Max Planck Institut fuer Biochemie. In 1991 she founded the first Laboratory of peptide chemistry at the University of Florence starting peptide-based translational research. Since 2001 she is Associate Professor of bioorganic chemistry at the University of Florence and since 2013. She is author of 246 peer-reviewed articles: 138 articles in peer reviewed scientific journals and 108 articles in peer reviewed books.

Dr. Márcio V. Ramos is a Full Professor in the Federal University of Ceará Brazil. He holds a Doctorate in Protein Biochemistry from the Federal University of Ceará, Brazil with a one and a half year at Université Paul Sabatier, Toulouse, France and a post-doctoral stage at Université des Sciences et Technologies de Lille, France. For nearly 20 years he has studied plant proteins in terms of chemistry, structure, functions and biotechnological applications. Currently he investigates the role of latex proteins in plant defense against enemies and the potential use of latex proteins as biotechnological tools in agriculture and medicine.

Dr. Uversky obtained Ph.D. from Moscow Institute of Physics and Technology (1991) and D.Sc. from Institute of Experimental and Theoretical Biophysics (1998). Dr. Uversky is an Associate Professor at the Department of Molecular Medicine at the University of South Florida. He has authored over 600 scientific publications and edited several books and book series on intrinsically disordered proteins, protein structure, function, folding and misfolding. Dr. Uversky is an Editor-in-Chief of the Intrinsically Disordered Proteins journal and an editor of several other scientific journals, including Current Protein & Peptide Science, Protein & Peptide Letters, PeerJ, and Biochemistry & Biophysics Reports

Full Professor of Human and Comparative Physiology at the Department of Physiological Sciences,Institute of Biology, University of Brasilia (UnB), Brazil, since 2018. She received her Ph.D. degree in Protein Chemistry in 1999 from the Institute of Biology, UnB, for her studies on antimicrobial peptides from maize seeds. She was a visiting researcher under the supervision of Prof. Peter Roepstorff at the University of Southern Denmark (SDU) during 2011‐2013 working on quantitative proteomics. Investigator of the National Council for Scientific and Technological Development (CNPq) since 2009. She is an Editorial Board Member for Protein & Peptide Letters. She currently serves as president of the Brazilian Society of Toxinology (SBTx). Her current research interests are peptide drug discovery (focusing on the exploitation of the Brazilian fauna as a source for new drugs) and quantitative proteomics.

M. Michael Gromiha is working as a Professor at Indian Institute of Technology (IIT) Madras, India. His main research interests are structural analysis, prediction, folding and stability of globular and membrane proteins, protein interactions and development of bioinformatics databases and tools. He has published over 210 research articles, 40 reviews, 5 editorials, 10 databases, 30 web servers and a book on Protein Bioinformatics: From Sequence to Function by Elsevier/Academic Press. His papers received more than 10,000 citations and h-index is 55.

Tao Li (李涛) earned his Doctoral degree at West China School of Medicine in 2009. From 2014 to 2016, he worked as a visiting scholar in University of Washington in Seattle under the guidance of Dr Rong Tian. Currently, he is the Director of Laboratory of Mitochondria and Metabolism in West China Hospital, Sichuan University. Tao’s primary research focus is the role of mitochondria and metabolism in the pathogenesis of cardiovascular diseases. He has published a series of papers in this area, including Cell Metab, Circ Res, Antioxid Redox Signal, Free Radic Biol Med, and serves as reviewer for multiple journals, such as Nat Metab, Circulation, et al. He is a member of Biophysical Society of China.

Mai Suan Li is Professor of Physics at the Institute of Physics, Polish Academy of Sciences and Scientific Advisor to the Institute for Computational Science and Technology, Ho Chi Minh city, Vietnam. He obtained a Ph.D. in theoretical physics from Chisinau State University, Moldova, and a habilitation degree from the Institute of Physics, Polish Academy of Sciences. His research interests are: development of coarse-grained models for studying protein folding and aggregation, factors governing protein aggregation, co-translational folding on ribosomes, protein unfolding under an external mechanical force, and computer-aided drug design for Alzheimer's disease, influenza A virus, breast cancer, and Covid-19.

Maria Luisa Mangoni graduated in Biology with honours at Sapienza University of Rome. In 1998, she worked at Karolinska Institutet, Stockholm, in the lab of Prof. Emeritus Hans G. Boman where she studied the role of antimicrobial peptides (AMPs) in innate immunity. In 2002, she received her PhD in Biochemistry from Sapienza University. In 2002 she was appointed as Assistant Professor and in 2012 as Associate Professor, same University. In 2014 she gained the abilitation to Full Professor in Biochemistry. Her current research interests include the structural functional characterization of amphibian skin AMPs and their derivatives for the development of new anti-infective agents. She was an invited speaker at several international conferences.

Professor Papanikolaou obtained his Bachelor's degree from Manhattan College (1987) and from New York Medical College (Biochemistry & Molecular Biology, Ph.D, 2000). He received a Ruth Kirschtein National Research Service Award postdoctoral fellowship in Molecular Oncology from the Institute for Cancer Genetics, Columbia University College of Physicians and Surgeons (2000- 2003). He was a Research Associate (Pathology, Genetics and Development, Columbia University College of Physicians and Surgeons, 2003-2007) a Bioanalyst and Group Leader at the Ludwig Institute for Cancer Research (2007-2009). Since 2009 he has been in the Laboratory of Biological Chemistry, School of Medicine, at the Aristotle University of Thessaloniki in Macedonia, Greece.

Konstantinos Poulas was born in 1970 in Athens. He studied biology at the Athens University where he also completed his Ph.D. Since 2003, he has been faculty member of the Department of Pharmacy at the University of Patras. He has worked for 20 years in order to understand the structure and function of Acetylcholine Receptor(s) and its interaction with autoantibodies or monoclonal antibodies. He has studied the molecular structure of monoclonal antibodies and fragments of the acetylcholine receptor. In addition, he has developed two new methodologies for the crystallization of proteins, for one of which he is having an international patent. For the last year his group is studying the interaction of the SARS-CoV-2 Spike protein with the nicotinic cholinergic system. He has about 100 publications in peer reviewed journals and he is currently participating in HORIZON2020 and national projects.

Dr. Soeda currently serves as an Assistant Professor at the Department of Life Science at the Faculty of Science, Gakushuin University, Japan, since 2018. He received a Ph.D. degree in 2009 from the Department of Clinical Pharmacology, University of Toyama, for his studies on lipid phosphatase SHIP2 in peripheral tissues and the CNS. He was a Postdoctoral fellow under the supervision of Prof. Akihiko Takashima at the RIKEN, and National Center for Geriatrics and Gerontology during 2009-2015 working on screening for tau aggregation inhibitors. Served as an Assistant Professor of Fukushima Medical University during 2015-2017. His current research interests are tau-targeted drug discovery and the mechanism of tau-related toxicity or dysfunction in neurodegenerative diseases.

Dr. Golam Jalal Ahammed received his Ph.D. in Olericulture with major focus on Plant Stress Physiology and Hormonal Regulation from the Zhejiang University, China in 2012 and did postdoctoral work at the Institute of Pesticide and Environmental Toxicology and Institute of Crop Science of Zhejiang University from 2013-2017. He joined the Department of Horticulture, College of Forestry, Henan University of Science and Technology, Luoyang, China in 2018 as an Associate Professor. Dr. Ahammed authored over 60 research papers in peer-reviewed journals. He is an editorial board member of some reputed journals, including Current Peptide and Peptide Science, and Scientific Reports.

Xing Chen Professor of China University of Mining and Technology and founding director of Institute of Bioinformatics, China University of Mining and Technology. He serves as associate editor or editorial board member for academic journals such as Frontiers in Genetics, Frontiers in Plant Science, BMC Systems Biology, Scientific Reports, Current Protein & Peptide Science, Current Proteomics. In recent years, he published 93 SCI papers in the journals such as Bioinformatics, PLOS Computational Biology, Nucleic Acids Research, Briefings in Bioinformatics, Cell Death & Disease. His H-index is 28 and his publication has been cited more than 2800 times by the journals.

Prof. P. Shukla is working as Professor and Head, Department of Microbiology at Maharshi Dayanand University, Rohtak, India. Prof. Shukla was also awarded with Indo-USA Professorship by American Society of Microbiology at University of Cincinnati, USA. His current research interests are in the fields of enzyme technology, protein bioinformatics and microbial biotechnology. Prof. Shukla has written five books, twenty two book chapters, one patent and have published more than 61 papers in peer reviewed reputed international journals. He received several awards, including Received ‘Prof. S.B. Saksena, Award’ in life sciences (1999), Danisco India Award in Probiotics & Enzyme Technology (2010), AMI-Alembic Award 2015 etc. He is also working as General Secretary, Association of Microbiologists of India (AMI) a premier scientific society in Asia.

Dr. Maria Caterina Baccari, Associate Professor of Physiology at the Department of Experimental and Clinical Medicine, Section of Physiological Sciences, University of Florence (Italy). She graduated in Biology, received her PhD in Physiology from the University of Florence, Italy. She is a visiting PhD student at the Department of Anatomy and Developmental Biology, University College of London. Her research field is mainly focused on the nervous and hormonal control of gastrointestinal motility, with particular reference to the non-adrenergic, non-cholinergic neurotransmission.

Kwang-Hyun Baek is a full professor of Department of Biomedical Science and a director of Cell & Gene Therapy Research Institute at CHA University in Korea. He received his Ph.D. from the department of Zoology and Genetics at Iowa State University in US in 1995 and worked as a postdoctoral research fellow in the division of Genetics at Brigham and Women’s Hospital and in the department of Pediatric Oncology at Dana-Farber Cancer Institute, Harvard Medical School. Current research and clinical interests are in the molecular genetics of ubiquitination and deubiquitination systems relevant to various cancers.

Valeri Barsegov was born in Baku, Azerbaijan in 1969. He graduated from high school in 1986 with Silver Medal and entered Moscow State University same year. He was drafted to perform mandatory military service during 1987-1989. He joined Chemistry Department at UML as an Assistant Professor in 2006, and he was promoted to the rank of Associate Professor in 2012 and Full Professor in 2017. Dr. Barsegov is also an Adjunct Professor at Moscow Institute of Physics and Technology. Computational group of Dr. Barsegov works on diverse problems including biomechanics of thrombosis and haemostasis, nanomanipulations with biological particles (viruses, microtubules), and cell mitosis.

Prof. Rolf Boelens (1951) studied physical chemistry at the University of Groningen (Netherlands). He completed his Ph.D. in the Department of Biochemistry of the University of Amsterdam with a study on ligand binding and electron transfer in cytochrome c oxidase using EPR. For a postdoc he went to the NMR group of Robert Kaptein. Currently he is professor of biomolecular NMR spectroscopy at Utrecht University, head of the Department of Chemistry and board member of the Bijvoet Center for Biomolecular Research. His research resulted in over 340 publications (> 13500 citations, h-index 61).

Dr. Katherine L.B. Borden is a Professor of Pathology and Cell Biology at the University of Montreal and an investigator at the Institute for Research in Immunology and Cancer. She holds a Canadian Research Chair in Molecular Biology of the Nucleus. She received her PhD from Yale University in Molecular Biophysics and Biochemistry. Her research activities focus on understanding protein factors involved in RNA processing, and how these can decouple the transcriptome from the proteome, and how dysregulation of these factors contributes to cancer.

Claudio Cabello-Verrugio is a Biochemist and received his Ph.D. degree in Cell and Molecular Biology from Catholic University of Chile. He is Associate Professor and researcher at Universidad Andres Bello in Chile and his research is focused on studying the mechanism involved in skeletal muscle diseases. In the last 10 years, he has published more than 40 manuscripts in the field of skeletal muscle biology. Actually, the emphasis on his research is to elucidate the effect of managing the renin-angiotensin system (RAS) on skeletal muscle atrophy produced by diverse causes such as aging, disuse, sepsis and chronic diseases.

Born in Italy, Oliviero Carugo studied Chemistry at the University of Pavia. Initially interested in structural chemistry and structure correlation studies, he extended progressively his scientific interests towards structural bioinformatics and structural biology. After research experiences at the European Molecular Biology Laboratory (Heidelberg, Germany) and at the International Centre for Genetic Engineering and Biotechnology (Trieste, Italy), he presently teaches Structural Bioinformatics and Chemistry at the University of Pavia, Italy and at the University of Vienna, Austria.

Fabrizio Ceciliani, DVM, PhD, is an Associate Professor of Veterinary Pathology at the University of Milano. He graduated in Veterinary Medicine at the University of Milano. In 1994 gained a PhD in Biochemistry and in 1995 gained a post doc position in Molecular Biology at the University of Milano. Current interests include the immune response in white blood cells and the involvement of adipose tissue in innate immune response. He teaches Molecular Pathology at the School of Veterinary Biotechnology of the University of Milano.

Dr. Chattopadhyay, Scientist-G & Director at ICMR-NITM Belagavi India, is a leading Ethnomedicine and Virus specialist, working on difficult-to-treat diseases. He has established personal contact with diverse tribes, and validated their age-old-tradition for translating traditions into innovation. He has 8-patents, 4-leads, 4-Books, 55 popular and 137 research- articles. His h-Index is 33 and have 3541 citations. He is the editor, editorial member and reviewer of several peer-reviewed Journals of global repute, and served as PhD Guide, visiting Faculty, examiner and member of Research Advisory Board and Board of Studies of Universities. He is the recipient of several awards, Fellow of BSAC (UK), Member of DST-SERB Expert Committees, and produced 15 PhDs.

Dr. Alekha K. Dash received his bachelor’s and master’s degrees in Pharmacy from Jadavpur University, India, and a Ph.D. from the University of Minnesota, USA. Dr. Dash is the professor and chair of the Department of Pharmacy Sciences, Creighton University and the holder of the Gilbert F. Taffe Jr. Endowed Chair of Pharmacy. He serves as the Associate Dean for Research for the School of Pharmacy and Health Professions. He has made important research contributions in the fields of analytical method development for complex dosage forms, phase identification and phase quantification in solid matrices, and development and evaluation of novel drug delivery systems.

Bart De Spiegeleer was born in 1959 in Aalst, Belgium. He studied pharmacy at Ghent University, where he also completed in 1989 his Ph.D. on radiosynthesis, characterization and functionality of anticancer platinum complexes. He started in 1994 his own pharmaceutical consulting company, heading a group specialized in chemical-pharmaceutical development encompassing also GMP/GLP and regulatory affairs. He was also a board member of several start-up companies in the pharmaceutical and related health-products field. Since 2008, becoming full-time professor, he is head of Drug Quality and Registration (DruQuaR) laboratory at the Department of Pharmaceutical Analysis in Ghent University. He is author or coauthor of over 100 publications.

Dr. Luca Ferraro obtained a degree in Pharmacy from the University of Ferrara, Italy. He is a Professor of Pharmacology at the Dept. of Life Sciences and Biotechnology, University of Ferrara. He is currently affiliated with the Laboratory for Technologies of Advanced Therapies (LTTA – Tecnopolo), University of Ferrara as the Head of Service of "Animal models in drug testing." Since 2012, he is a member of the research team of the IRET Foundation (Ozzano Emilia, Bologna) for the study of neurodegenerative diseases. Dr. Ferraro is the author of about 150 publications in international journals in the field of Neuropharmacology and Neuroscience.

Dr. Alfred N. Fonteh obtained his Ph.D. degree (in 1989) in Biochemistry from University of London (England), UK. Dr. Fonteh is currently Senior Principal Analytical Biochemist as well as Director of Lipidomics & Proteomics at Huntington Medical Research Institutes (HMRI – Neurosciences), Pasadena, California, USA. His skills and expertise mainly lie in the subject areas/fields of Cancer Biology, Cell Culture, PCR, Flow Cytometry, Immunohistochemistry, Biotechnology, Gene Expression, Chromatography, Cell Signaling, and Western Blot Analysis. Dr. Fonteh, as an author/co-author, has published more than 70 articles in various journals, having a noteworthy number of total citations, i.e. over 2,590.

Prof. Dr Octavio Luiz Franco is graduated in Ciencias Biologicas from the Universidade Federal do Ceara´ (1998) and obtained his PhD in Biochemistry and Molecular Biology from the Universidade de Brasılia (2001). He is the head professor at the Universidade Catolica Dom Bosco and the Universidade Catolica de Brasilia, a visiting professor at the Universidade Federal de Juiz de Fora, a researcher at the Post- Graduation program of Physics Education from UCB, a researcher at the Universidade de Brasilia in the program of Molecular Pathology and researcher from CNPq. He has experience in biochemistry, proteomics and molecular modeling. He currently works on the following subjects: antimicrobial peptides, immunomodulators, antifreezing and proteome of animals, plants and microorganisms. His work has also focused on the development of bioproducts and bioprocesses. At the moment he has more than 250 manuscripts already published.

Oxana V. Galzitskaya is head of the Bioinformatics group at the Institute of Protein Research Russian Academy of Sciences (since 2008). She graduated from the Moscow Physical-Technical Institute (1990, Honorary Diploma). She did Ph.D. in Biophysics (Institute of Theoretical and Experimental Biophysics, Pushchino, 1996). She is author of more than 150 peer-reviewed publications. She is awarded for Outstanding Russian Young Scientists, 1997 and for Doctor of Science of Russian Science Support Foundation. She is member of the Editorial Boards of "Current Protein and Peptide Science", “Open Biochemistry”, “Open Bioinformatics”, and “Open Journal of Biochemistry”, the Editorial Board of World Journal of Biological Chemistry, Austin Biometrics and Biostatistics, Associate Editor for the Journal of Alzheimer's Disease.

Dr. Marcelo González Ortiz studied Biochemistry at Universidad de Concepción, Chile, and has a Doctoral degree in Physiological Sciences from the Universidad Católica de Chile. He has been working at the Universidad de Concepción, first in the Department of Physiology and the Department of Obstetrics and Gynecology since 2009. Dr. Ortiz's research interests are in the description of placental vascular regulation mechanisms, both physiological conditions and in pregnancy diseases such as gestational diabetes and preeclampsia. In his laboratory, Dr. Ortiz uses different methods of cellular biology, molecular biology, biochemistry and vascular reactivity to elucidate the mechanisms of vascular regulation from the molecular interactions to organ function. Recently, he has been studying the regulation of potassium channels and their interaction with nitric oxide signalling in human placenta, to determine the potential alterations of these mechanisms in gestational diabetes.

Mathias Hallberg is a Professor in Molecular Research on Drug Dependence at Uppsala University, Sweden. His research covers the involvement of peptidergic mechanisms in cognitive behavior, chronic pain and drug dependence. His current activities besides molecular research on drug dependence, e.g. anabolic steroids and opiates, include the development of drug-like peptidemimetics of bioactive degradation products in the Renin Angiotensin and the Tachykinin Systems. He is the Director of a program within the Swedish Science for Life Laboratory aimed at developing peptides and drug-like ligands to the AT2 receptor as potential pharmaceutical agents.

De-Shuang Huang is the professor of computer science of Tongji University. He received the Ph.D. degrees in electronic engineering from Xidian University, Xian, China, in 1993. He is currently the Fellow of the International Association of Pattern Recognition (IAPR Fellow). He has published over 420 papers in international journals, international conferences proceedings, and book chapters, and three monographs (in Chinese). His research interests include protein-protein interaction analysis, motif mining in DNA sequence, and deep neural networks.

Doctor Paola Irato graduated in Biological Sciences from the University of Milan in 1984. In 1988, she obtained the research doctorate in Evolutionary Biology from University of Padua. Since 1991, she has been a researcher of general physiology. Dr. Irato has always been interested in heavy metal detoxification systems. She has been in-charge of the project “The determination of biological stress indices in mugilidae from high and low anthropic stress brackish environments”.

Dr. Rizwan Hasan Khan has received his Ph.D in Biotechnology from Aligarh Muslim University, India during the period of 1992-1996. Currently he is working in the area of protein structure, function, protein misfolding / aggregation and amyloid induction and inhibition at Aligarh Muslim University. He has published paper in journals like Scientific reports, Biomacromolecules, Langmuir, PLoS ONE, Biochemistry, BBA, BBRC etc. He has worked with Prof. I.J. Goldstein at University of Michigan USA as BOYSCAST Fellow and with Prof. Steve Perkins at University of London as Commonwealth Fellow. He has guided 16 PhD thesis and completed 12 research projects. He had published around 250 papers in the journals of international repute with H index of 35 and total citation around 4650.

Lukasz Kurgan has Ph.D. in Computer Science (2003) from the University of Colorado at Boulder. Since 2015 he is with the Department of Computer Science at the Virginia Commonwealth University as the Qimonda Endowed Professor. Before that he was a Professor of Electrical and Computer Engineering at the University of Alberta. Dr. Kurgan is an Area Editor for structural bioinformatics of BMC Bioinformatics and Associate Editor of Intrinsically Disordered Proteins, PLoS ONE, Neurocomputing, Current Protein and Peptide Science, and Protein and Peptide Letters. More details are on the web site of his lab at http://biomine.ece.ualberta.ca/.

Prof. Hang Fai (Henry) Kwok currently holds the Associate Professor and the Consultant of Histopathology Core position in the Faculty of Health Sciences at the University of Macau. Henry completed a period of postdoctoral training at the Queen’s University Belfast (QUB) and then moved to industry as Senior Scientist in the Fusion Antibodies Limited, which was recently listed on the FTSE All-Share AIM index on the London Stock Exchange as Fusion Antibodies Plc. (FAB). His interests include protease biochemistry research with biologics development to pursue novel therapeutic, prognostic and diagnostic approaches in the treatment of cancer and other diseases.

Dr. Liu is a Professor of pharmacology and the dean of School of Pharmaceutical Sciences, Southern Medical University. Dr. Liu is also the director of Guangdong Provincial Key Laboratory of Drug Screening. Dr. Liu is the chair-elect of Division of Anti-inflammatory and Immunopharmacology of Chinese Pharmacological Society (CPS). From 2002, Dr. Liu has already published more than 120 SCI papers in academic journals which were cited more than 2,500 times with an h-index of 28. Moreover, Dr. Liu got 9 Chinese patents and 1 United States patent, as well as 9 Chinese and 2 PCT patent applications.

Dr. SONIA LONGHI obtained a PhD in molecular biology from the University of Milan in 1993. She got a HDR in structural virology from the University of Aix-Marseille I in 2003. Presently she is Director of Research (DR1) at the Center for the National Scientific Research (CNRS), and head of the "Structural Disorder and Molecular Recognition" group within the laboratory Architecture et Fonction des Macromolécules Biolgiques (AFMB). Her scientific focus is on intrinsically disordered proteins (IDPs) and the mechanistic and functional aspects of the interactions they establish with partners. She has authored more than 100 scientific publications.

Dr. Xi Ma is originally from China and received his initial public health training at the Peking University Health Science Center in Beijing. Drawn by the opportunity for the harmonious integration of oncology, cell biology and molecular biology, he completed his medical immunology fellowship at the Peking University Health Science Center. He has been a faculty with the China Agricultural University and an Associate Professor since 2012 focusing on the research of animal nutrition requirements and metabolic modulation. He currently specializes in intestinal microbiota mature and immune system development, as well as regulation of glycose and lipid metabolism in mammals. Dr. Ma is also an adjunct faculty member at UT Southwestern Medical Center in Dallas, focused on autophagy and nutritional modulation.

PAOLO MAGNI received a degree in Medicine and a post-doctoral degree in Endocrinology at the Universita' degli Studi di Pavia (Italy) and a PhD degree in endocrinology and metabolism at the Universita' degli Studi di Milano (Italy). He is professor of pathology at the Universita' degli Studi di Milano (Italy). His research domains include the molecular pathophysiology of metabolic diseases (obesity, diabetes, metabolic syndrome, dyslipidemia, atherosclerosis) and the nutritional/nutraceutical modulation of cardiometabolic risk, aging and health-related issues. He is conducting both experimental and clinical research. He is the author or co-author of over 85 scientific papers in peer-reviewed international journals.

Mauro Manno (ORCID 0000-0001-9843-0428) received is PhD at the University of Palermo and it is now researcher at the National Research Council of Italy (CNR) Institute of Biophysics (IBF) Palermo, Italy. Current research focuses on the thermodynamic and conformational stability of protein in solutions and on the common pathways of self-assembly leading to different biologically relevant structures. The main research lines are the following. (i) Mechanical and structural properties of gels formed by amyloid fibrillar structures. (ii) Intermolecular interactions and solution stability in fibril forming protein solutions, including model and prion proteins. (iii) Structures and mechanisms of inactivation of proteins involved in serpinopathies, a class of genetic conformational diseases. (iv) Structural and mechanical properties of extracellular nanovescicles, involved in physiological and oncogenic processes.

Associate Professor Martin gained her PhD in Chemistry from The Australian National University. She obtained the Alexander von Humboldt and Fulbright awards to undertake post-doctoral stays in Germany and USA, respectively, before her first academic position at The Flinders University of South Australia. She currently holds a position at Monash University (since 2003) where she has a research focus on the electrochemistry of cytochrome P450 enzymes involved in steroid biosynthesis, membrane action of antimicrobial and amyloidogenic peptides and incorporation of biomolecules into novel materials especially those with semiconducting properties.

Dr. Ghulam Md Ashraf currently working as Associate Professor at King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia. He received his PhD in Biochemistry from Aligarh Muslim University (India) in 2010. Dr. Ashraf has been involved in 14 research projects funded by various agencies of Saudi Arabia, and is a member of renowned professional associations and organizations. He has published 239 articles (total citations: 3301 h-index: 27, i10-index: 89) in journals and books of international repute. Dr. Ashraf is also involved in editorial capacity in many reputed journals, like PLOS one, Scientific Reports, Frontiers in Neuroscience, Current Proteins and Peptides, Journal of Proteomics, to mention a few. Dr. Ashraf’s prime field of research is neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. His lab is currently investigating the effect of anti-diabetic drugs in effective reversal of anti-psychotic drugs induced weight gain in psychosis conditions in Wistar rats. Dr. Ashraf’s lab is also investigating the effect of anti-diabetic drugs in animal models of psychosis and Alzheimer’s disease.

Dr. Tapan Kumar Mohanta is presently serving as a Researcher in the University of Nizwa Oman. Before joining the University of Nizwa, Dr. Mohanta was working as a Research Professor in Yeungnam University, Gyeongsan, South Korea from April 2014 to February 2018. Dr. Mohanta also worked as a Postdoctoral Research Associate in G.B. Pant University of Agriculture and Technology, Pant Nagar, India from September 2011 to April 2012 and National Institute of Plant Genome Research, New Delhi, India from April 2012 to March 2014. Dr. Mohanta has completed his MS Bioinformatics (2007) and PhD degree (2011) from University of Turin, Italy and M.Sc. Biotechnology (2006) degree from North Orissa University, India. Dr. Mohanta has published more than 50 SCI/SCI-E indexed research publications in Q1, Q2, and Q3 journals in the field of plant genomics, proteomics, molecular biology and metabolomics. Dr. Mohanta has contributed several book chapters and other research publications as well.

Sylviane Muller is a Distinguished class research director in the French Centre National de la Recherche Scientifique (CNRS) and Professor at the Institute of Advanced Studies of the Strasbourg University (USIAS), in charge of the chair Therapeutic immunology. She is the Director of the CNRS Molecular and cellular biology Institute (IBMC) in Strasbourg, Chair and Director of the CNRS Unit entitled Immunopathology and therapeutic chemistry, and Head and coordinator of the Drug discovery Center for cancer and inflammation Medalis awarded 'Laboratory of Excellence’ (2011-2020).

Tzi Bun Ng received his PhD degree in endocrinology and protein biochemistry. He pursued postdoctoral research in hormones and sabbatical research in biotechnology. He is a professor at the Chinese University of Hong Kong. He has published over 700 papers in international journals and nearly 100 book chapters. He has served as an assessor of candidates for the degree of PhD and for promotion to various professorial ranks in various universities and research grant applications submitted to various national funding agencies. His research interests encompass milk proteins, antipathogenic proteins, mushroom polysaccharoproteins and polysaccharopeptides, and protease inhibitors.

Jinyong Peng received his Master’s in Medical Science from Zhejiang University, and then received PhD from Second Military Medical University. He did post-doctoral degree from the Dalian Institute of Chemical Physics. Currently, he is working as the Dean of College of Pharmacy, Dalian Medical University. He is serving as an editorial member of the British Journal of Pharmacology, Archives of Toxicology, Pharmacological Research, etc. He has published many papers in Theranostics, Redox Biology, and Archives of Toxicology. He is a member of Chinese Pharmacological Society, and Chinese Chemical Society.

BOTOND PENKE got his master’s degree in biology and chemistry at Eotvos Lorand University Budapest, then PhD degree at Jozsef Attila University in Szeged, Hungary. He is professor of medicinal chemistry at Szeged University. His research domains include peptide synthesis, protein chemistry and biochemistry, protein structure, neurodegenerative diseases, drug design. He has been the PI of several experimental EU research projects. He is the author or co-author of 280 peer-reviewed scientific papers in international journals.

Dr. Permyakov obtained a doctorate (Ph.D.) in physics and mathematics from the Moscow Institute of Physics and Technology and defended a doctor dissertation (Doctor of Sciences) in biology in Moscow State University. Previously he worked in the Institute of Theoretical and Experimental Biophysics (Russia) and the Ohio State University (USA). Currently Dr. Permyakov is a director of the Institute for Biological Instrumentation (Russia). He has published 10 monographs and more than 160 articles.

Alessandro Pini is Associate Professor of Biochemistry at the Department of Medical Biotechnology, University of Siena, Italy. He is founder and president of the biotech company SetLance srl (www.setlance.com). Author of publications on international journals of biochemistry, biotechnology, oncology and microbiology, of several book chapters and one book for italian students of Biotechnology. Inventor in 10 international patents regarding antibodies or peptides as therapeutic agents. Teacher of biochemistry and biotechnology at the University of Siena, University of Insubria Varese, University of Perugia, Consorzio Siena Ricerche, National Institute for Cancer Research, Genoa, in Italy, and at the Swiss Federal Institute of Technology, Zurich, in Switzerland.

Dr. Insaf Ahmed Qureshi has received his Ph.D. in Biotechnology from Jamia Hamdard, India and worked as a Postdoctoral Fellow in Nanyang Technological University, Singapore. Currently, he is working as Senior Assistant Professor in University of Hyderabad, India and his group is focused on characterization of human parasitic proteins through structural and functional approaches. He has been recipient of several coveted fellowships and has served as a Visiting Fellow in University of Missouri, Columbia, USA. He has published more than sixty research articles in peer-reviewed journals like European Journal of Medicinal Chemistry, International Journal of Biological Macromolecules, BBA General Subjects, BBRC etc.

Dr. Maria Ruzzene obtained her Ph.D. degree (in 1991) in Molecular and Cellular Biology and Pathology from University of Padova, Padova, Italy. Dr. Ruzzene is currently Associate Professor of Biochemistry, in the Department of Biomedical Sciences, at University of Padova. She has primarily been involved in projects concerning protein phosphorylation and structural and functional characterization of protein kinases and phosphatases. Additionally, her present research is mainly focused on protein kinases involved in signal transduction in health and diseases, the regulation of cell death/survival, and developing specific kinase inhibitors. Dr. Ruzzene, as an author/co-author has published over 100 manuscripts in various journals, and her documents have received a considerable number of total citations, i.e. more than 4,370.

Mauro Salvi received his B.S. degree in Biology (1998) and Ph.D. degree in Biochemistry and Biophysics (2002) from the University of Padova, Italy. Mauro Salvi joined the faculty at the University of Padova in 1996 as Assistant Professor and was promoted to Associate Professor in 2015. His current research projects are all addressed to work out phosphorylation-based regulatory mechanisms in different signal transduction pathways studying the kinase (function, regulation, partners etc.) and the target protein substrate/s (physiological role of phosphorylation) with a combination of in silico, in vitro and in cell experimental approaches.

Dr. Shoseyou is a faculty member of the Hebrew University of Jerusalem. Prof. Shoseyov’s research is in plant molecular biology protein engineering and nano-biotechnology. His group focuses on Bio-Inspired Nanocomposite materials. He has authored or co-authored more than 160 scientific publications and is the inventor or co-inventor of 46 patents. Prof. Shoseyov received the Outstanding Scientist Polak Award for 2002, the 1999 and 2010 Key Award for Innovative and Applied Research and The 2012 Israel Prime Minister Citation for Entrepreneurship and Innovation. He is the scientific founder of 10 companies.

Dr. Laishram R. Singh is presently working as an Assistant Professor at the University of Delhi. Dr. Singh is a well-known enzymologist and protein biochemist with 15 years of research experience. He has published more than 40 publications in many esteemed journals in the field of proteostatic regulation and protein covalent modification by homocysteine. He has also edited books and authored several chapters in many books published by Springer, InTech and Elsevier etc. Currently Dr. Singh’s research group is interested in developing strategies to remove toxic protein deposits in neuronal cells and cardiomyocytes using proteostatic modulators and small molecule compounds.

Dr Singh received his PhD in Biotechnology from National Centre for Cell Sciences, Pune, India in 2010 and obtained Postdoctoral experience from City of Hope Medical Centre, CA, USA. Currently, he is an Assistant Professor and heading Molecular Medicine laboratory in the Department of Human Genetics and Molecular Medicine, Central University of Punjab, India. He has guided 5 PhD and more than 40 Masters level thesis and published more than 40 articles, 3 patents and edited a book. His current research includes the role of mito-miRs in cancer progression, cancer cell signalling and anticancer drug discovery.

Jiangning Song is a Senior Research Fellow and group leader in the Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Faculty of Medicine, Monash University, Melbourne, Australia. He is also affiliated with the Monash Centre for Data Science, Faculty of Information Technology, Monash University. He received his D.Eng degree in bioengineering from Jiangnan University, China and his Ph.D degree in Computer Science from Monash University, Australia. His research interests include bioinformatics, computational biology, machine learning, data mining, and pattern recognition.

Dr. Kyoungho Suk is a member of editorial board for the journal. He is currently a professor of Department of Pharmacology, Kyungpook National University (KNU) School of Medicine (Daegu, Korea), and the director of Brain Science & Engineering Institute of KNU. He obtained his Ph.D. in Immunology at University of California at Davis in 1994, and M.S. degree in Immunology at Cornell University in 1991. He graduated from KNU with the genetic engineering major in 1989. Dr. Suk received his postdoctoral training in the division of Rheumatology, Yale University School of Medicine, and he has been a visiting professor at Harvard Medical School between 2008 and 2009, during which he participated in large-scale experiments and systems biology approaches toward understanding of disease networks and pathways. Dr. Suk is the author of more than 200 papers published in peer-reviewed journals and holds patents on various therapeutic targets and lead compounds that could be used for the diagnosis or therapy of neuroinflammatory and neurodegenerative diseases.

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards in 2011, and the Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

Dr. Alla P. Toropova, PhD. She had published of about 230 papers in international journals on QSPR/QSAR analysis for inorganic and organometallic compounds, in particular, thermodynamical properties of coordination compounds of bioactive metals (Cu, Ni, Co, etc), and thermodynamic properties (e.g. solubility) of nano substances. She's been involved in EC funded projects: ORCHESTRA, ANTARES, OSIRIS, NanoBRIDGES, PreNanoTox, NanoPUZZLES etc. She is participant in work of Editorial Boards of scientific journals (as a reviewer).

Dr. Lam-Son Phan Tran is Head of the Stress Adaptation Research Unit at RIKEN Center for Sustainable Resource Science, Japan. His current research interests are elucidation of the roles of phytohormones and their interactions in abiotic stress responses, as well as translational genomics of legume crops with the aim to enhance crop productivity under adverse environmental conditions.

Dr. Jianxin Wang is the Associate Dean and a full professor in School of Information Science and Engineering,Central South University, Changsha, Hunan, China. He received his B.Sc. (Computer Science) and M.Sc. (Computer Science) from Central South University of Technology, China, in 1992 and 1996, respectively, and his Ph.D. degree in computer science from Central South University, China, in 2001. His research interests include genome analysis and assembly, biological network analysis, network medicine and big data analytics for healthcare, etc. He has published more than 100 papers, which have been published in various journals (Bioinformatics, Algorithmica, IEEE/ACM Transactions on Computational Biology and Bioinformatics, Proteomics, Methods, BMC Bioinformatics, BMC Genomics, etc), conferences (ISMB, BIBM, GIW, ISBRA, etc) and books. He is a co-inventor of more than twenty patents in China, and has received many awards from agencies such as NSFC and Ministry of Education of the People’s Republic of China.

Dr. Dongdong Wang received his Ph.D. in Pharmacognosy from the Sichuan University in Chengdu of China in 2015, and did postdoctoral work at University of Vienna in Austria from 2015-2018 and at University of Zurich in Switzerland from 2018-2020. He is currently working at the University of Zurich as a senior scientist, and at Guizhou University of Traditional Chinese Medicine as an Associate Professor. He has published more than 30 papers in high quality journals. He now is focusing on cardiovascular diseases and natural products from traditional medicine.

Dr. Guodong Wang obtained his MSc from Shanghai Institute of Plant Physiology & Ecology (SIPPE), East China Normal University (ECNU) in 2003. Later in 2009, he obtained his PhD from Wageningen University, Netherlands. Dr. Wang is currently working as a Professor at the College of Life Science, Shaanxi Normal University, China.

Dr. Williams received his Bachelor’s and Master’s degrees from Memphis State University in 1970 and 1973 respectively. He received his Ph.D. from the University of Georgia, Athens, in 1976. He continued his post-doctoral research studies at Roswell Park Memorial Institute in Buffalo. His initial faculty position was in the Department of Microbiology and Immunology at Kirksville College of Osteopathic Medicine, Missouri. Dr. Williams joined The Ohio State University in 1982 and is currently a professor in the Department of Cancer Biology and Genetics, College of Medicine, at The Ohio State University. He also holds appointments in the Department of Microbiology, College of Biological Sciences, as well as, the Institute for Behavioral Medicine Research at The Ohio State University.

Dr. Zhong-Yin Zhang is Distinguished Professor of Medicinal Chemistry, the Robert C. and Charlotte P. Anderson Chair in Pharmacology, and Head of the Department of Medicinal Chemistry and Molecular Pharmacology in the College of Pharmacy at Purdue University. Professor Zhang's research spans the disciplines of chemistry and biology with an emphasis on the structure and function of protein tyrosine phosphatases (PTPs), PTP-mediated signaling, mechanistic enzymology, and design and synthesis of PTP inhibitors as tool compounds to interrogate PTP function and as novel therapeutics for the treatment of cancer, diabetes and obesity, autoimmune disorders, and infectious diseases. He has authored more than 240 publications, holds 17 patents, consults for several pharmaceutical companies, and he is an internationally recognized authority in the field of PTPs.

Dr. Qi Zhao received his Bachelor degree and PhD from Wuhan University and Chinese Academy of Sciences in 2005 and 2011, respectively. Since 2011, he has been a faculty member as a lecturer and associate professor in Liaoning University, China. Now he is a full professor in the University of Science and Technology Liaoning, China. His research interests include bioinformatics, big data, machine learning and network analysis. Dr. Zhao has been a part of several well-known research journals including Scientific Reports, PLOS ONE, Frontiers in Genetics and many more and has published 56 SCI journal papers in the fields of bioinformatics.

Dr. Balducci Enrico through his research and work experience acquired the competences of the biochemical methods, cell culture, and molecular biology techniques. Currently, he is an Aggregate Professor at the School of Biosciences and Biotechnologies and School of Biosciences and Medicine Veterinary, University of Camerino (MC).

Bruno Casciaro graduated in 2013 in Pharmaceutical Biotechnologies with honors at Sapienza University of Rome and received his PhD in Biochemistry in 2017 with a thesis entitled “Different approaches to optimize the antimicrobial properties of cationic peptides: substitution by non-coded amino acids and conjugation to nanoparticles”. His current research is focused on the characterization of the biological properties of natural bioactive compounds, in particular antimicrobial peptides and therapeutic proteins, and on different approaches to conjugate them to nanoparticle systems.

Dr. Eldeeb received his B.Sc in Chemistry (with the highest honor) from Cairo University in 2009. He moved to Canada in 2011 to study for his Ph.D. at the University of Alberta. He studied the molecular mechanisms by which the N-end rule degradation pathways regulate cell death in cancer-derived cell lines. In December 2017, he become a lecturer and investigator of Biochemistry at Cairo University. In June 2018, he joined the Montreal Neurological Institute at McGill University to investigate the molecular mechanisms by which mitochondrial quality control are deregulated in Parkinson’s disease. Dr. Eldeeb has authored more than 14 peer-reviewed articles and has been an ad hoc reviewer for many scientific journals in the biochemistry, molecular and cellular biology field.

Ricardo Lagoa graduated in Biochemistry at University of Coimbra (Portugal) and completed the PhD in Biotechnology and Biomedical Research at University of Extremadura (Spain) in 2011. Currently, he is Assistant Professor at ESTG-Polytechnic Institute of Leiria and also integrates UCIBIO-Applied Molecular Biosciences Unit, University NOVA of Lisbon, Portugal. Research interests include oxidative stress in toxicology and disease, natural compounds, biocatalysts and biopolymers applications.

Dr. Yang Liu received his MD at Xi’an Jiaotong University and then came to Second affiliated hospital for his postgraduate surgical training. In 2017 was promoted to associate Professor of Surgery at Xi’an Jiaotong university and then he did his postdoc training at Harvard university, Boston, US. Dr. Yang clinical areas of expertise are in gastroenterology surgery. The GI & general surgery department which he served has a high volume surgical practice involving the care of patients with gerontology diseases. His particular areas of interest are in minimally-invasive approaches to the treatment of abdominal cancer patients. Dr. Yang runs a highly productive research program focused on the gut-liver axis.

Dr. Grazia Maugeri is an Adjunct Professor in the Section of Anatomy, Histology and Movement Sciences of University of Catania, Italy. She received her PhD in Neuroscience from the University of Catania, Italy in 2018. She is a Visiting Professor in Human Anatomy at the University of Gorazde, Bosnia and Herzegovina. Her current research projects are focused on elucidating molecular mechanisms underlying the progression of neurodegenerative diseases, such as diabetic retinopathy and amyotrophic lateral sclerosis, understanding the role of different peptides, such as vasoactive intestinal polypeptide (VIP) and Pituitary adenylate cyclase-activating polypeptide (PACAP) in these neurodegenerative diseases.

Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, indigenous herb believed to exert anabolic effects on bone. After completing his Ph.D, he did his Postdoctoral work at the Department of Radiation Oncology, Chungbuk National University, South Korea. He worked on the role of Epidermal growth factor/receptor signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) as Assistant Professor and working on Polycystic ovarian syndrome and cancer biology.

Dr. Pandey received Ph.D. degree in Biotechnology from Department of Biochemistry University of Lucknow, Lucknow, India under the supervision of Prof. U. N. Dwivedi. After Ph.D. he has worked in CSIR-CIMAP as DST SERB Young Scientist from 2015-2018. Currently, he joined Department of Biochemistry, University of Lucknow as CSIR Senior Research Associate under CSIR Pool Scientist’s Scheme. His research area of interest is Enzymology, Genetic engineering, Bioinformatics etc. He has contributed 40 research papers / reviews and two book chapters.

Dr. Anket Sharma is currently working as post-doctoral scientist at State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, China. Before joining as post- doctoral scientist, he worked as assistant professor at DAV University, Jalandhar, India. He completed his M.Phil. and Ph.D. from Guru Nanak Dev University, Amritsar, India. He was also a DST-INSPIRE Fellow from Department of Science & Technology, Government of India. He has authored 67 articles in journals and 14 chapters in books of international repute.

Dr. Rahul Pratap Singh earned his B. Pharm. and M. Pharm. degrees from Bundelkhand University, Jhansi, India. He has completed his Ph.D. in Pharmaceutics (cancer nanomedicines) in 2017, under the supervision of Dr. M.S. Muthu and Prof. B.L. Pandey from Banaras Hindu University, Varanasi. Dr. Singh is an Assistant Professor at the Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Sohna, Gurgaon, India. He has authored dozens of scientific publications and currently editing one book on lung cancer nanomedicines. He received several fellowships; awards including research grant from Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, Dr. Singh is working as a research project reviewer of the Department of Science and Technology, New Delhi since 2017 onwards, He is an Editor-Board Member of several other scientific journals, including Coronaviruses, Current Protein & Peptide Science, Acta Scientific Pharmaceutical Sciences and International Research Journal of Pharmacology

Prior to his appointment as a professor at the Jiangsu University, Professor Sun was a PhD in Food Science at the University of Massachusetts-Amherst. His research are focused on 1) identifying potential disease preventive dietary components (nutraceuticals, food-derived peptides), elucidating their molecular mechanisms, 2) understanding the molecular mechanisms of food chemical pollutants (pesticides) and impaired glucose or lipid metabolism, with the long-term goal of developing diet-based strategies for the prevention of chronic diseases.

Wenzheng Bao received his Ph.D in computer science from Tongji University in 2018. He received the master degree in computer science from the University of Jinan in 2015. He currently works for school of information and electrical engineering, Xuzhou University of Technology, Xuzhou, China. His research interests include bioinformatics, machine learning, computational biology and proteomics.

Dr Martiniano Bello Ramírez obtained BSc. Biological Pharmaceutical Chemistry, from the University of Veracruz (2003), MSc. Biochemical Sciences, National Autonomous University of Mexico (2006), and Ph. D. Biochemical Sciences, National Autonomous University of Mexico (2010). Currently, he is a Research Professor at the Superior School of Medicine of National Polytechnic Institute of Mexico. He has published more than 50 articles in well-reputed journals. Besides, he is a reviewer of many journals such as European Journal of Medical Chemistry, Pharmaceuticals, Journal of Molecular Modeling, PlosOne, Plos Computational Biology, Proteins: Structure, Function, and Bioinformatics, Molecular BioSystems, Physical Chemistry Chemical Physics, Open Chemistry, Anti-Cancer Agents in Medicinal Chemistry and many more.

Dr. Mehedi is a bioinformatics and statistical scientist. He is currently a postdoctoral fellow at the Tulane University, USA. Before his current position, he worked at the Japan Society for the Promotion of Science (JSPS) international PD fellow in the Kyushu Institute of Technology, Japan. He also worked as a researcher at the Chinese University of Hong Kong. He received his PhD degree in bioinformatics from the China Agricultural University, Beijing, in 2016. His main research interests include protein structure prediction, machine learning, data mining, computational biology, and functional genomics.

Dr. Ghulam Md Ashraf currently working as Associate Professor at King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia. He received his PhD in Biochemistry from Aligarh Muslim University (India) in 2010. Dr. Ashraf has been involved in 14 research projects funded by various agencies of Saudi Arabia, and is a member of renowned professional associations and organizations. He has published 239 articles (total citations: 3301 h-index: 27, i10-index: 89) in journals and books of international repute. Dr. Ashraf is also involved in editorial capacity in many reputed journals, like PLOS one, Scientific Reports, Frontiers in Neuroscience, Current Proteins and Peptides, Journal of Proteomics, to mention a few. Dr. Ashraf’s prime field of research is neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. His lab is currently investigating the effect of anti-diabetic drugs in effective reversal of anti-psychotic drugs induced weight gain in psychosis conditions in Wistar rats. Dr. Ashraf’s lab is also investigating the effect of anti-diabetic drugs in animal models of psychosis and Alzheimer’s disease.

Dr. Anket Sharma is currently working as post-doctoral scientist at State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, China. Before joining as post- doctoral scientist, he worked as assistant professor at DAV University, Jalandhar, India. He completed his M.Phil. and Ph.D. from Guru Nanak Dev University, Amritsar, India. He was also a DST-INSPIRE Fellow from Department of Science & Technology, Government of India. He has authored 67 articles in journals and 14 chapters in books of international repute.

Professor Hubing Shi received his Ph.D. in Biochemistry and Molecular Biology from the Tsinghua University in 2007 and continued postdoctoral research at the University of California at Los Angeles from 2008-2015. He joined the State Key Laboratory of Biotherapy as professor in China in 2015. His research interests focus on discovery of the acquired resistance mechanisms in targeted therapy and development of novel combinatorial regimens with state-of-the-art treatment in clinics.

Zhaoliang Su has been appointed as a Professor at the Jiangsu University, China. He is currently an Executive Director of International Genome Center, Jiangsu University and focuses on the potential mechanisms of inflammatory disorders, especially, cardiac inflammatory injury, inflammatory resolution and cardiac functional remodeling as well as cancer immune escape.

Dr. Timothy Veenstra received his PhD in biochemistry from the University of Windsor in Canada followed by completion of a post-doctoral fellowship at the Mayo Clinic in Rochester, Minnesota. It was at the Mayo Clinic that he recognized the value of applying mass spectrometry (MS) to biomedical research. He has spent most of his career in research, utilizing MS in the fields of oncology and neurology to identify biomarkers for disease detection as well as identifying protein interactions key to disease progression. He has co-authored almost 400 peer-reviewed manuscripts and is the author of the book “Proteomic Applications in Cancer Detection and Discovery”.

Dr. Wei Wang is a Professor at the Henan Agricultural University (HAU) and a Principal Investigator of the State Laboratory of Wheat and Maize Crop Science, China. He received a PhD from the Institute of Botany, Chinese Academy of Sciences in 1995. He did his Postdoctoral studies at CSIC (Spain, 1999-2001) and University of Siena (2002-2006), where he began his work on crop genomic and proteomic works. In 2006, he moved to HAU, where he was promoted to Full Professor and then distinguished Professor in Henan province. His research focuses on maize omics and improvement. Besides, he is a member of the editorial board at Frontiers in Plant Science (Associate Editor), PLOS ONE (Academic Editor), and Acta Physiologiae Plantarum (Associate Editor).